创新药延续回调，资金逢低买入，科创创新药ETF（589720）连续5日净流入额超2.6亿元

Core Viewpoint - The innovative drug sector continues to experience a downward trend, with the Sci-Tech Innovation Drug ETF (589720) declining nearly 15% over the past two months, despite recent capital inflows indicating potential buying opportunities [1]. Group 1: Market Performance - The Sci-Tech Innovation Drug ETF has seen a net inflow of over 260 million yuan in the last five days and over 350 million yuan in the last ten days, suggesting investor interest during the pullback [1]. - The recent sentiment in the innovative drug sector has declined, but the ongoing business development (BD) activities indicate that the sector's overall health remains sustainable [1]. Group 2: Industry Trends - The trend of "innovation + internationalization" in the innovative drug industry remains unchanged, with expectations for increased elasticity in the sector following the short-term adjustments [1]. - The Sci-Tech Innovation Drug ETF focuses on innovative drug companies listed on the Sci-Tech Innovation Board, tracking a representative index of 30 high-quality companies, primarily in the high-growth biotech sector [1].